Pharmacological Evaluation and In-Silico Study of Sabinene as a Potential Anti-Alzheimer’s Drug in AlCl3-Induced Rat Model via BACE-1 and GSK3β Modulation
Neurochemical Research · 2025
DOI: 10.1007/s11064-025-04523-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, 2025. Verfasst von Pankti Parmar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, L.J. Institute of Pharmacy, L.J. University, SG highway, Sanand cross-road, Ahmedabad, Gujarat, 382210, India. Hauptthemen laut MEDLINE: Glycogen Synthase Kinase 3 beta, Amyloid Precursor Protein Secretases, Alzheimer Disease, Aspartic Acid Endopeptidases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 92 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a progressive and debilitating neurodegenerative disorder. β-site amyloid precursor protein cleaving enzyme 1 (BACE1) and glycogen synthase kinase-3β (GSK3β) contribute to Aβ plaque development, tau hyperphosphorylation, neurofibrillary tangles, and neuronal dysfunction in AD pathogenesis. This study aimed to investigate the neuroprotective potential of sabinene in an Aluminum chloride (AlCl3)-induced model of AD in male Wistar rats. Thirty male Wistar rats were randomly divided into six groups (n = 6 per group). Group I (control) received normal saline for 30 days. Groups II-V were administered only AlCl3 (100 mg/kg, orally) for 20 consecutive days to induce AD-like pathology, which was confirmed through behavioral assessments. Following induction, Group II (AD control) received 1% Tween 80; Group III (standard treatment) was administered rivastigmine (2.5 mg/kg); while Groups IV-VI received sabinene at doses of 5, 10, and 20 mg/kg, respectively, for 10 days 1 h prior to AlCl3. Behavioral evaluations were conducted on days 0, 20, and 31. On the 31st day, animals were sacrificed for biochemical and molecular analyses. In silico molecular docking studies revealed that sabinene exhibited a higher binding affinity towards AD-related targets (BACE1, GSK-3β, TACE, and AChE) compared to rivastigmine. In vivo, sabinene treatment significantly mitigated oxidative stress, restored antioxidant enzyme activities, reduced pro-inflammatory cytokine levels, AChE, BACE1, and GSK3β expression, and ameliorated histopathological alterations in the rat brain. Thus, sabinene exerts potent neuroprotective and disease-modifying effects in AlCl3-induced AD via AchE, BACE-1, and GSK3β Modulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, L.J. Institute of Pharmacy, L.J. University, SG highway, Sanand cross-road, Ahmedabad, Gujarat, 382210, India.
- Department of Pharmaceutical Chemistry, L.J. Institute of Pharmacy, L.J. University, Ahmedabad, Gujarat, 382210, India.
- Department of Pharmacology, L.J. Institute of Pharmacy, L.J. University, SG highway, Sanand cross-road, Ahmedabad, Gujarat, 382210, India. dr.dipa.israni@ljku.edu.in.
ORCID-Profile: Dipa Israni
Zitieren
APA
Parmar, P., Chauhan, H., Modi, P., & Israni, D. (2025). Pharmacological Evaluation and In-Silico Study of Sabinene as a Potential Anti-Alzheimer’s Drug in AlCl3-Induced Rat Model via BACE-1 and GSK3β Modulation. Neurochemical Research. https://doi.org/10.1007/s11064-025-04523-7
Vancouver
Parmar P, Chauhan H, Modi P, Israni D. Pharmacological Evaluation and In-Silico Study of Sabinene as a Potential Anti-Alzheimer’s Drug in AlCl3-Induced Rat Model via BACE-1 and GSK3β Modulation. Neurochemical Research. 2025. doi:10.1007/s11064-025-04523-7
BibTeX
@article{Parmar2025,
author = {Parmar, Pankti and Chauhan, Heena and Modi, Palmi and Israni, Dipa},
title = {Pharmacological Evaluation and In-Silico Study of Sabinene as a Potential Anti-Alzheimer’s Drug in AlCl3-Induced Rat Model via BACE-1 and GSK3β Modulation},
journal = {Neurochemical Research},
year = {2025},
doi = {10.1007/s11064-025-04523-7}
}
EUVIMED